From single‐cell cloning to high‐yield influenza virus production – implementing advanced technologies in vaccine process development

Tilia Zinnecker; Najd Badri; Diogo Araujo; Kristin Thiele; Udo Reichl; Yvonne Genzel; Tilia Zinnecker; Najd Badri; Diogo Araujo; Kristin Thiele; Udo Reichl; Yvonne Genzel

doi:10.1002/elsc.202300245

2024 Volume 24

Article Contents

Next Previous

RESEARCH ARTICLE Open Access

From single‐cell cloning to high‐yield influenza virus production – implementing advanced technologies in vaccine process development

More Information

Published online: 18 February 2024
Engineering in Life Sciences 24(4), Article number: 10.1002/elsc.202300245 (2024) | Cite this article

Rights and permissions
Copyright: © 2024 by the author(s). Exclusive Licensee Maximum Academic Press, Fayetteville, GA. This article is an open access article distributed under Creative Commons Attribution License (CC BY 4.0), visit https://creativecommons.org/licenses/by/4.0/.

About this article

Cite this article

Tilia Zinnecker, Najd Badri, Diogo Araujo, Kristin Thiele, Udo Reichl, Yvonne Genzel. 2024. From single‐cell cloning to high‐yield influenza virus production – implementing advanced technologies in vaccine process development. Engineering in Life Sciences. 24:245 doi: 10.1002/elsc.202300245

Tilia Zinnecker, Najd Badri, Diogo Araujo, Kristin Thiele, Udo Reichl, Yvonne Genzel. 2024. From single‐cell cloning to high‐yield influenza virus production – implementing advanced technologies in vaccine process development. Engineering in Life Sciences. 24:245 doi: 10.1002/elsc.202300245

Download PDF

Article Metrics

Article views(38) PDF downloads(15)